Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 24Other hematologic neoplasm 18Gastrointestinal 18Thoracic 12Gynecologic 12Tumor-Agnostic 10Lymphoid 8Genitourinary 8Other solid neoplasm 6CNS 6Plasma cell 5Sarcoma 4Head & Neck 4Myeloid 3Dermatologic 3Endocrine 2Other 1NET 1

Conditions

Weight Loss 1Obesity 1Multiple Endocrine Neoplasia Type 1 1

Interventions

Exercise 27Metformin 24Methods 14Radiotherapy 13Early Intervention, Educational 13Educational Status 12Counseling 12Surveys and Questionnaires 10Standard of Care 10Nutrition Assessment 9Resistance Training 8Diet Therapy 8Cisplatin 8naloxegol 7Tirzepatide 7Diet 7alvimopan 6Psychiatric Rehabilitation 6Fibroblast Growth Factor 7 6Caloric Restriction 6Radiation 5Low-Level Light Therapy 5Liraglutide 5Injections 5Exenatide 5Dexamethasone 5Cryotherapy 5semaglutide 4angiotensin I (1-7) 4Vitamin D 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Palliative Care × Other × Clear all
NCT02938897 2016-10-19

Telenutrition Weight Loss Study for Men

West Virginia University

Phase NA Completed
60 enrolled
EndocrineOther

Obesity, Weight Loss, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡